Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxaverine Effects on Ocular Blood Flow in AMD and Glaucoma
NCT00709449Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- May 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of moxaverine in age-related macular degeneration (AMD), primary open-angle glaucoma (POAG), sponsored by Medical University of Vienna. Started May 2008; status: completed.
02
Drugs
moxaverine
03
Conditions
age-related macular degeneration (AMD)primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT00709449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00709449.